TRANexamic Acid to Reduce Bleeding in BURN Surgery (TRANBURN)
The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial
Sponsor: Centre Hospitalier Saint Joseph Saint Luc de Lyon
This PHASE4 trial investigates Burns and Surgery and is currently completed. Centre Hospitalier Saint Joseph Saint Luc de Lyon leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Mar 2024 — May 2024 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Mar 2022 — Mar 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 5 earlier versions
-
Jan 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE4
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
May 2019 — Jan 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
May 2017 — May 2019 [monthly]
Recruiting PHASE4
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Saint Joseph Saint Luc de Lyon
- Société Française d'Anesthésie et de Réanimation
For direct contact, visit the study record on ClinicalTrials.gov .